EyePoint Pharmaceuticals, Inc.

Q1 2023 13F Holders

Symbol
EYPT
CUSIP
30233G209
Type
Equity
Class
COM NEW
Num filings
71
Total reported value, excl. options
$85.6 M
Manager Report Date Value ($000) Shares Option Type